Glycosaminoglycans from Alzheimer's disease hippocampus have altered capacities to bind and regulate growth factors activities and to bind tau.
Glycosaminoglycans (GAGs), including heparan sulfates and chondroitin sulfates, are major components of the extracellular matrix. Upon interacting with heparin binding growth factors (HBGF), GAGs participate to the maintaintenance of tissue homeostasis and contribute to self-healing. Although severa...
Main Authors: | Minh Bao Huynh, Mohand Ouidir Ouidja, Sandrine Chantepie, Gilles Carpentier, Auriane Maïza, Ganlin Zhang, Joao Vilares, Rita Raisman-Vozari, Dulce Papy-Garcia |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0209573 |
Similar Items
-
New roles of glycosaminoglycans in α-synuclein aggregation in a cellular model of Parkinson disease.
by: Sonia Lehri-Boufala, et al.
Published: (2015-01-01) -
Tau protein, oxidative stress and glycosaminoglycan mimetics. Links for new therapeutic possibilities in Alzheimer’s disease
by: Zhang, Ganlin
Published: (2011) -
Structural Perspectives on Glycosaminoglycan-Binding Proteins and Their Receptors
Published: (2019) -
Structural Characterization & Glycosaminoglycan Binding of the Small Cytokine Pleiotrophin
Published: (2020) -
The role of glycosaminoglycan binding and oligomerisation for chemokine function in vivo
by: Johnson, Zoë
Published: (2003)